News

Zacks Investment Research on MSN13h
RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study
Shares of Rhythm Pharmaceuticals RYTM rallied 17.1% on Monday after the company announced that it has met the primary ...
Fierce Pharma14h
Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs, including GLP-1s
While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...